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Backgrounds: Bronchioloalveolar carcinoma (BAC) is deﬁned as an 
adenocarcinoma with pure bronchioloalveolar growth pattern and no 
evidence of stromal, vascular or pleural invasion by 1999 WHO clas-
siﬁcation. Although BAC has unique clinical and radiological pre-
sentations, BAC has been deﬁned inconsistently in various series. We 
analyzed the clinical features, treatment outcome and prognostic factors 
of 141 BAC patients in a single institution. 
Methods: From September 1994 to December 2004, a total of 5,063 
patients were diagnosed of non-small lung cancer (NSCLC) at Sam-
sung Medical Center in Korea. Of 5,063 patients, 141 patients (2.8% of 
NSCLC, 5.2% of adenocarcinoma) were diagnosed of BAC according 
to the 1999 WHO criteria. The clinical data including radiological fea-
tures, treatment modalities, relapse and vital status were retrospectively 
obtained.
Results: Among the 141 patients, 100 patients (71%) underwent surgi-
cal resection with curative intent. The male to female ratio was 0.85:1 
and the median age was 62 years (range, 29 - 83). Only 29% of the 
patients were current or ex-smokers. Most patients (61%) had clini-
copatholgic stage I, 5% stage II, 8% stage III, and 26% of the patients 
presented with stage IV disease. The most common initial radiological 
presentation was solitary nodule (63%) followed by multiple nodules 
in both lungs (18%), inﬁltrating or pneumonic mass (9%), multiple 
nodules in the same lung (6%), and a cavitary mass (4%). The most 
frequent location of the tumor was the right upper lobe (28%) followed 
by the right lower lobe (17%), the left lower lobe (16%), the left upper 
lobe (9%), and the right middle lobe (6%). The estimated 5-year overall 
survival rate of the 100 patients who underwent surgical resection was 
71.4 %, and the median survival has not been reached yet. Among the 
resected patients, 24 patients developed relapse mostly in the lung (19 
patients, 78%). The median survival was 6.9 months for the 39 patients 
without surgical resection. At the multivariate analysis, initial radio-
logical presentation with solitary nodule and curative resection were 
favorable prognostic factors for survival.
Conclusion: Pure BAC is uncommon lung adenocarcinoma in Korea. 
Patients with localized, resectable disease and initial radiological ﬁnd-
ing of solitary nodule have a signiﬁcantly better survival.
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Akopov, Andrey1,2 Mosin, Igor2 Filippov, Denis1 Agishev, Alexei1 
Ramazanov, Ramazan2 
1 Research Institute of Pulmonology, St.Petersburg, Russia 2 Pavlov 
Medical University, St.Petersburg, Russia 
Background: Results of partial resection of left atrium in lung cancer 
remain controversial. The study analysed 15-year experience with this 
surgery. 
Methods: From Jan 1991 to Dec 2005 28 patients with lung cancer 
underwent lung resection with partial resection of the left atrium. There 
were 25 men and 3 women at the average age of 64,3 years. Histologi-
cal types: 18 squamous cell carcinomas (64%), 5 adenocarcinomas 
(18%), 2 adenosquamous carcinomas (7%), 2 mucoepidermoid carcino-
mas (7%) and 1 atypical carcinoid (4%). Pathologic analysis identiﬁed 
11 patients with N0 disease (39%), 6 patients with N1 disease (22%) 
and 11 patients with N2 disease (39%). Tumor inﬁltration of atrial wall 
was diagnosed pathologically in 20 patients (71%) and invasion of the 
origin of pulmonary viens in remaining 8 patients (29%). All atrial 
resections were performed using mechanical steplers. 
Results: Right-sided operation was performed on 16 patients (57%), 
left-sided on 12 patients (43%). 26 patients (93%) underwent pneumo-
nectomy, 2 patients (7%) - lobectomy. 23 patients (82%) underwent 
complete resection, 5 operations were microscopically incomplete (2 
- tumor cells in bronchial resection margin, 3 - last lymph node re-
moved was metastatic, no positive atrial resection margin). The median 
intensive care unit stay and hospital stay was 3 days and 18 days. The 
in-hospital mortality was 4% (1 patient), postoperative complications 
developed in 5 patients (18%). The 1-year survival was 69%, the 5-year 
survival was 17%, median survival time - 23 months. 
Conclusions: In selected lung cancer patients partial resection of left 
atrium may improve control of the disease without increasing mortality 
and morbidity.
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Background: Video-assisted thoracic surgery (VATS) for radical 
lobectomy is a developing technique in the surgical treatment of non-
small cell lung cancer (NSCLC). Evidence suggests that VATS lobec-
tomy can be performed safely and may be associated with decreased 
hospital stay and post-operative morbidity. Despite this, the procedure 
is only performed in select centres around the world and has failed to 
gain widespread acceptance. One of the often cited deterrents is the 
perceived inadequacy of VATS lobectomy as an oncological procedure. 
With a recent publication of a meta-analysis suggesting that mediastinal 
lymph node dissection (MLND) has superior 4-year survival compared 
with lymph node sampling in NSCLC, the importance of assessing the 
quality of MLND performed by VATS is necessary. Our objective was 
to determine whether lymph node specimens from VATS lobectomy 
were of similar quality to those of open lobectomy (via thoracotomy).
Methods: A retrospective comparison of 70 VATS lobectomies with 
70 open lobectomy controls was performed. Controls were matched for 
anatomic location (i.e. lobe) as well as clinical TNM stage. All patients 
had histologically conﬁrmed NSCLC and MLND. The total number 
of lymph nodes resected and the number of nodes resected per station 
were compared. 
Results: The total number of lymph nodes resected during MLND per-
formed by VATS is at least equal to open lobectomy. For certain lymph 
node stations, the number of nodes resected may be higher by VATS 
than in open cases.
Conclusion: MLND performed by VATS is equivalent to thoracotomy. 
From a radical lymphadenectomy perspective VATS lobectomy for 
lung cancer is an adequate oncological procedure.
